Bio-Techne Corporation is a market leader in high-quality biological reagents used in the life science market, manufacturing high-quality proteins, antibodies and immunoassays. I think the company will benefit from the long-term growth in cell Recommended For You ### Create a free account to read the full article Already registered? Sign in Create free account By creating an account using any of the options above, you agree to the &amp; or Continue with Google Continue with Apple About TECH Stock | Symbol | Last Price | % Chg | | | | | | Bio-Techne Corporation | 59.74 | 1.63% | | | * 1D * 5D * 1M * 6M * 1Y * 5Y * 10Y ###### Chart Combination chart with 2 data series. View as data table, Chart The chart has 1 X axis displaying Time. Data ranges from 2025-07-23 09:30:00 to 2025-07-28 13:30:00. The chart has 1 Y axis displaying values. Data ranges from 54.215 to 59.96. End of interactive chart. Market Cap $9.21B PE (FWD) Yield 0.54% Rev Growth (YoY) 4.72% Short Interest 4.03% Prev. Close $58.78 More on TECH Sorry, this data cannot be displayed at the moment. Related Stocks | Symbol | Last Price | % Chg | | | | | | TECH | 59.74 | 1.63% | | | * 1D * 5D * 1M * 6M * 1Y * 5Y * 10Y ###### Chart Chart with 145 data points. View as data table, Chart The chart has 1 X axis displaying Time. Data ranges from 2025-07-23 09:30:00 to 2025-07-28 13:30:00. The chart has 1 Y axis displaying values. Data ranges from 54.215 to 59.96. End of interactive chart. Trending Analysis Trending News Follow us Download app * * * Account * Account Login * Manage My Portfolio * Privacy * * * Subscriptions * * * Investing Groups * * * Learn * * * * Stock Upgrades &amp; Downgrades * * * * * * * * * * * * Analysis by Sector * * * * * * Top Indexes * * * * * * * * * * * * News by Sector * * * Earnings * * * * * * Contact us * * * * * * © 2025 Seeking Alpha %20%7C%20Seeking%20Alpha&amp;p=https%3A%2F%2Fseekingalpha.com%2Farticle%2F4805168-bio-techne-q4-preview-nih-funding-cut-and-tariffs-impacts-initiate-at-sell&amp;r=&lt;=718&amp;evt=pageLoad&amp;sv=1&amp;cdb=AQAQ&amp;rn=435461)

Bio-Techne Q4 Preview: NIH Funding Cut And Tariffs Impacts, Initiate At Sell (NASDAQ:TECH)

The article discusses Bio-Techne Corporation's Q4 performance, highlighting the impact of NIH funding cuts and tariffs on its business. It includes stock data, market cap, and financial metrics, with a focus on the company's position in the life science market.